We present the HyperProbe consortium: a five-years, multinational, EU-funded project started in October, 2022, that aims at developing innovative hyperspectral imaging technologies for clinical translation. HyperProbe works towards providing highly enhanced neuronavigation during glioma resection.
HyperProbe consortium: transforming neuronavigation in glioma surgery with hyperspectral imaging / Giannoni L.; Toaha A.; Marradi M.; Degl'Innocenti D.R.; Ezhov I.; Caredda C.; Gautheron A.; Fort F.; Schneider F.; Berhouma M.; Bonaudo C.; Lange F.; Artemiou A.; Balazs E.; Krischak K.; Gordebeke P.; Alfieri D.; Ruckert D.; Montcel B.; Puppa A.D.; Picart T.; Tachtsidis I.; Pavone F.S.. - ELETTRONICO. - (2024), pp. 0-0. (Intervento presentato al convegno 2024 Clinical and Translational Biophotonics, Translational 2024 - Part of Optica Biophotonics Congress: Biomedical Optic tenutosi a usa nel 2024).
HyperProbe consortium: transforming neuronavigation in glioma surgery with hyperspectral imaging
Giannoni L.;Toaha A.;Marradi M.;Degl'Innocenti D. R.;Bonaudo C.;Alfieri D.;Pavone F. S.
2024
Abstract
We present the HyperProbe consortium: a five-years, multinational, EU-funded project started in October, 2022, that aims at developing innovative hyperspectral imaging technologies for clinical translation. HyperProbe works towards providing highly enhanced neuronavigation during glioma resection.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
